Moomoo AIのまとめ
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a significant ownership stake in Altimmune Inc., a biopharmaceutical company. According to the filing, State Street Corporation has shared voting power over 3,667,576 shares and shared dispositive power over 3,909,286 shares of Altimmune's common stock. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Altimmune Inc. The subsidiaries of State Street Corporation listed in the filing as beneficial owners of the securities include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as investment advisors (IA).
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a significant ownership stake in Altimmune Inc., a biopharmaceutical company. According to the filing, State Street Corporation has shared voting power over 3,667,576 shares and shared dispositive power over 3,909,286 shares of Altimmune's common stock. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Altimmune Inc. The subsidiaries of State Street Corporation listed in the filing as beneficial owners of the securities include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as investment advisors (IA).
マサチューセッツ州ボストンに本社を置く金融サービスおよび銀行持株会社であるState Street Corporationは、2024年6月30日に米国証券取引委員会（SEC）に修正されたSchedule 13Gを提出し、バイオ医薬品企業のAltimmune Inc.の重要な所有権を示しています。提出によると、State Street Corporationは、Altimmuneの普通株式に対して3,667,576株の投票権を共有し、3,909,286株の議決権を共有しています。申請では、これらの株は業務遂行上取得され、Altimmune Inc.の支配権を変更または影響を与える目的ではないと...すべて展開
マサチューセッツ州ボストンに本社を置く金融サービスおよび銀行持株会社であるState Street Corporationは、2024年6月30日に米国証券取引委員会（SEC）に修正されたSchedule 13Gを提出し、バイオ医薬品企業のAltimmune Inc.の重要な所有権を示しています。提出によると、State Street Corporationは、Altimmuneの普通株式に対して3,667,576株の投票権を共有し、3,909,286株の議決権を共有しています。申請では、これらの株は業務遂行上取得され、Altimmune Inc.の支配権を変更または影響を与える目的ではないと主張しています。申請書に掲載されているState Street Corporationの子会社は、投資顧問（IA）に分類されるSSGA Funds Management、Inc.、State Street Global Advisors Europe Limited、State Street Global Advisors Limited、およびState Street Global Advisors Trust Companyです。
役に立った
役に立たない